Amicogen, Inc.

République de Corée

Retour au propriétaire

1-27 de 27 pour Amicogen, Inc. Trier par
Recheche Texte
Affiner par
Type PI
        Brevet 16
        Marque 11
Juridiction
        International 20
        États-Unis 7
Date
Nouveautés (dernières 4 semaines) 1
2026 juillet 2
2026 (AACJ) 2
2024 1
2023 10
Voir plus
Classe IPC
C07K 1/22 - Chromatographie d'affinité ou techniques analogues basées sur des procédés d'absorption sélective 4
B01D 15/38 - Adsorption sélective, p. ex. chromatographie caractérisée par le mécanisme de séparation impliquant une interaction spécifique non couverte par un ou plusieurs des groupes , p. ex. chromatographie d'affinité, chromatographie d'échange par ligand ou chromatographie chirale 3
C07K 14/31 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant de bactéries provenant de Micrococcaceae (F) provenant de Staphylococcus (G) 3
A23L 33/18 - PeptidesHydrolysats de protéines 2
A61K 38/00 - Préparations médicinales contenant des peptides 2
Voir plus
Classe NICE
05 - Produits pharmaceutiques, vétérinaires et hygièniques 10
29 - Viande, produits laitiers et aliments préparés ou conservés 7
01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture 6
03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser. 6
30 - Aliments de base, thé, café, pâtisseries et confiseries 6
Voir plus
Statut
En Instance 3
Enregistré / En vigueur 24

1.

Z DOMAIN VARIANT OF PROTEIN A WITH INCREASED IMMUNOGLOBULIN ELUTION RATE, AND USE THEREOF

      
Numéro d'application KR2025008239
Numéro de publication 2026/155301
Statut Délivré - en vigueur
Date de dépôt 2025-06-16
Date de publication 2026-07-23
Propriétaire AMICOGEN, INC. (République de Corée)
Inventeur(s)
  • Yun, Young Sung
  • Lee, Mi Kyoung
  • Yoon, Ji Houn
  • Wang, Eun Seon
  • Li, Hong Xian
  • Oh, Min Jin
  • Park, Jong Eun
  • Lim, Su Jin

Abrégé

The present application relates to a protein A variant with increased immunoglobulin elution efficiency and, more specifically, to: a Z domain variant in which an amino acid at a specific position in the Z domain (B domain variant) of protein A is mutated to have immunoglobulin elution efficiency superior to that of the Z domain; and a use thereof.

Classes IPC  ?

  • C07K 14/31 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant de bactéries provenant de Micrococcaceae (F) provenant de Staphylococcus (G)
  • C07K 1/22 - Chromatographie d'affinité ou techniques analogues basées sur des procédés d'absorption sélective
  • C07K 16/00 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux
  • B01D 15/38 - Adsorption sélective, p. ex. chromatographie caractérisée par le mécanisme de séparation impliquant une interaction spécifique non couverte par un ou plusieurs des groupes , p. ex. chromatographie d'affinité, chromatographie d'échange par ligand ou chromatographie chirale

2.

MEDIUM COMPOSITION FOR CULTURING ANIMAL CELLS COMPRISING D-CHIRO INOSITOL OR DERIVATIVE THEREOF

      
Numéro d'application KR2026000090
Numéro de publication 2026/147265
Statut Délivré - en vigueur
Date de dépôt 2026-01-02
Date de publication 2026-07-09
Propriétaire AMICOGEN, INC. (République de Corée)
Inventeur(s)
  • Ko, Youngseok
  • Lee, Jisun
  • Lee, Jaeyoung
  • Ri, Hwajung
  • Choi, Su Lim
  • Kim, Sangjung

Abrégé

The present specification relates to: a medium composition for culturing animal cells, comprising D-chiro inositol (DCI) or a derivative thereof; and a method for culturing animal cells using same. Cells cultured in the medium composition can achieve excellent improvement in cell proliferation ability and reduction in lactic acid, which is a by-product in a culture medium.

Classes IPC  ?

  • C12N 5/00 - Cellules non différenciées humaines, animales ou végétales, p. ex. lignées cellulairesTissusLeur culture ou conservationMilieux de culture à cet effet
  • A23L 13/00 - Produits à base de viandeFarine de viandeLeur préparation et leur traitement
  • C12N 5/078 - Cellules du sang ou du système immunitaire
  • C12N 5/0775 - Cellules souches mésenchymateusesCellules souches dérivées du tissu adipeux

3.

DEACETOXYCEPHALOSPORIN C-PRODUCING MICROORGANISM FOR 7-ADCA PRODUCTION WITH HIGH CONCENTRATION AND HIGH PURITY AND PRODUCTION METHOD USING THE SAME

      
Numéro d'application 18488170
Statut En instance
Date de dépôt 2023-10-17
Date de la première publication 2024-05-16
Propriétaire AMICOGEN, INC. (République de Corée)
Inventeur(s)
  • Piao, Zhe
  • Yun, Young Sung
  • Lee, Hyeon Seo
  • Choi, Yeon Hee
  • Kang, Mi Suk
  • Piao, Xue Mei
  • Kim, You Mi
  • Lee, Ji Su
  • Li, Hong Xian
  • Seo, Dong Il
  • Jeong, Dong Won
  • Kim, Seung Ki

Abrégé

Disclosed herein are a microorganism with excellent deacetoxycephalosporin C (DAOC) productivity and a use thereof. A mutant microorganism with improved DAOC productivity and a use thereof for producing 7-aminodeacetoxycephalosporanic acid (7-ADCA) are provided.

Classes IPC  ?

  • C12P 13/02 - Amides, p. ex. chloramphénicol
  • C12N 9/02 - Oxydoréductases (1.), p. ex. luciférase
  • C12N 9/90 - Isomérases (5.)
  • C12N 15/80 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes eucaryotes pour champignons
  • C12P 17/18 - Préparation de composés hétérocycliques comportant O, N, S, Se ou Te comme uniques hétéro-atomes du cycle contenant plusieurs hétérocycles condensés entre eux ou condensés avec un système carbocyclique commun, p. ex. rifamycine

4.

IMMUNOGLOBULIN-BINDING PROTEIN VARIANTS WITH INCREASED ALKALI-TOLERANCE AND USE THEREOF

      
Numéro d'application 18305522
Statut En instance
Date de dépôt 2023-04-24
Date de la première publication 2023-11-09
Propriétaire AMICOGEN, INC. (République de Corée)
Inventeur(s)
  • Choi, Su Lim
  • Park, So Young
  • Park, Sol A
  • Sim, Yeo Won

Abrégé

Provided are immunoglobulin-binding protein variants with increased alkali tolerance, and uses thereof, and more particularly to immunoglobulin-binding protein variants with increased alkali tolerance relative to the wild type due to mutations in amino acids at specific positions in the B3 domain of the immunoglobulin-binding proteins

Classes IPC  ?

  • B01J 20/32 - Imprégnation ou revêtement
  • C07K 1/22 - Chromatographie d'affinité ou techniques analogues basées sur des procédés d'absorption sélective

5.

Polypeptide having cephalosporin C acylase activity and use thereof

      
Numéro d'application 18056385
Numéro de brevet 12024729
Statut Délivré - en vigueur
Date de dépôt 2022-11-17
Date de la première publication 2023-08-24
Date d'octroi 2024-07-02
Propriétaire AMICOGEN, INC. (République de Corée)
Inventeur(s)
  • Piao, Zhe
  • Wang, Eun Seon
  • Li, Hong Xian
  • Lee, Mi Kyoung
  • Son, Ah Reum
  • Lim, Su Jin

Abrégé

Disclosed herein are a polypeptide having cephalosporin C(CPC) acylase activity and a use thereof. More specifically, a mutant CPC acylase comprising a point mutation introduced thereinto, thereby exhibiting improved enzymatic activity and/or stability, and a use of the mutant CPC acylase for producing 7-aminocephalosporanic acid (7-ACA), are provided.

Classes IPC  ?

  • C12N 9/80 - Hydrolases (3.) agissant sur les liaisons carbone-azote autres que les liaisons peptidiques (3.5) agissant sur les liaisons amides des amides aliphatiques
  • C12N 15/63 - Introduction de matériel génétique étranger utilisant des vecteursVecteurs Utilisation d'hôtes pour ceux-ciRégulation de l'expression

6.

AMICOGEN

      
Numéro d'application 1732470
Statut Enregistrée
Date de dépôt 2023-02-17
Date d'enregistrement 2023-02-17
Propriétaire AMICOGEN, INC. (République de Corée)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 29 - Viande, produits laitiers et aliments préparés ou conservés
  • 30 - Aliments de base, thé, café, pâtisseries et confiseries
  • 32 - Bières; boissons non alcoolisées

Produits et services

Mixed vitamin preparations; pharmaceutical products for treating respiratory diseases and asthma; medical preparations for slimming purposes; medicines for human purposes; dietetic substances adapted for medical use; ferments for medical or veterinary use; nutritional supplements for medical use; adjuvants for medical purposes; antibiotic preparations; calcium supplements; food for babies (except lacteal flour for babies); medicines for the treatment of gastrointestinal diseases; chemico-pharmaceutical preparations; ferments for pharmaceutical purposes; allergy medications; ophthalmic preparations; nervines; cardiovascular pharmaceutical preparations; biological preparations for veterinary purposes; pharmaceutical agents affecting digestive organs; anti-inflammatory and antipyretic preparations; bouillons for bacteriological cultures; biological preparations; sterilising preparations; pharmaceutical products for the treatment of bone diseases; vitamin preparations; vaccines; pharmaceutical preparations for immunity adjustment; mineral food supplements; lactose for pharmaceutical purposes; pharmaceutical preparations for animals; pharmaceutical agents affecting metabolism; pharmaceutical preparations for treating diabetes; androgen preparations; pharmaceutical agents affecting sensory organs; nutritional supplements mainly based on lactic acid bacteria; nutritional supplements mainly based on aloe extracts; nutritional supplements mainly based on coenzyme Q10; nutritional supplements mainly based on grape seed extract; nutritional supplements mainly based on medicinal herbs; nutritional supplements mainly based on vitamin B complex (vitamin B1, B2, B12); nutritional supplements mainly based on fish oil for food; nutritional supplements mainly based on fucoidan; nutritional supplements mainly based on calcium derived from aquatic products; nutritional supplements mainly based on fructo-oligosaccharide from inulin derived from chicory roots; nutritional supplements mainly based on reishi mushroom extracts; nutritional supplements mainly based on folic acid; nutritional supplements mainly based on chitosan oligosaccharide derived from shell of crustaceans; nutritional supplements mainly based on garcinia cambogia; nutritional supplements mainly based on garlic; dietary drink mixes for loosing weight. Food products made from lactic acid bacteria; food products made from beans (excluding bean curds and foodstuffs made from bean curds); food products made primarily from fruits; yoghurt; milk; processed dairy products; lactic acid bacteria drinks; milk products; powdered milk (except for infants); processed meat products; processed vegetable products; cheese; processed seaweed products; protein milk; edible fats. Processed cereals; leaven; frozen yoghurt [confectionery ices]; fructo-oligosaccharide for culinary purposes; muesli; cereal-based processed products; oat-based food; farinaceous food pastes for human consumption; oatmeal; Korean rice-wine starter (Nuruk); baking powder; ferments for dough; wheat germ for human consumption; vinegar; ketchup [sauce]; processed coffee; cereal preparations; beverages with a tea base; glucose for food. Energy drinks containing carbohydrates/vitamins derived from fruits; fruit juices; powders for effervescing beverages; pastilles for effervescing beverages; non-alcoholic fruit extracts; non-alcoholic beverages; energy drinks containing vitamin C; soda pops; energy drinks containing medicinal herbs; energy drinks containing proteins/amino acids/calcium derived from milk; whey beverages; powders used in the preparation of fruit-based beverages; preparations for making non-alcoholic drinks; vegetable-based beverages and fruit-based beverages; energy drinks containing coenzyme Q10; carbonated water; energy drinks containing soybean milk.

7.

K·NUTRA

      
Numéro d'application 1726250
Statut Enregistrée
Date de dépôt 2023-02-17
Date d'enregistrement 2023-02-17
Propriétaire AMICOGEN, INC. (République de Corée)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 29 - Viande, produits laitiers et aliments préparés ou conservés
  • 30 - Aliments de base, thé, café, pâtisseries et confiseries
  • 32 - Bières; boissons non alcoolisées

Produits et services

Mixed vitamin preparations; medical preparations for slimming purposes; medicines for human purposes; ferments for medical or veterinary use; adjuvants for medical purposes; antibiotic preparations; calcium supplements; food for babies (except lacteal flour for babies); chemico-pharmaceutical preparations; allergy medications; cardiovascular pharmaceutical preparations; pharmaceutical agents affecting digestive organs; anti-inflammatory and antipyretic preparations; bouillons for bacteriological cultures; biological preparations; pharmaceutical preparations for immunity adjustment; mineral food supplements; lactose for pharmaceutical purposes; pharmaceutical preparations for animals; pharmaceutical agents affecting sensory organs; nutraceuticals for medical or therapeutic purposes; vitamin supplements; nutraceuticals mainly based on red ginseng; capsules for medicines; nutraceuticals mainly based on glucosamine derived from shell of crustaceans (such as crabs or shrimps); nutraceuticals mainly based on N-acetylglucosamine derived from shell of crustaceans (such as crabs or shrimps, etc.); nutraceuticals mainly based on N-acetylglucosamine derived from bone of molluscs (such as squid, etc.); nutraceuticals mainly based on chitosans/chitosan oligosaccharide derived from crustaceans shell/molluscs bone; nutraceuticals mainly based on lutein derived from marigold; nutraceuticals mainly based on lactic acid bacteria; nutraceuticals mainly based on pinitol derived from carob (legumes); nutraceuticals mainly based on collagen peptide derived from pig's skin; nutraceuticals mainly based on collagen peptide derived from fish scales; nutraceuticals mainly based on fucoxanthin derived from brown algae (such as seaweed or gulf weed, etc.); nutraceuticals mainly based on coenzyme Q10 derived from vegetables; nutraceuticals mainly based on probiotics derived from milk products; dietetic beverages adapted for medical purposes containing N-acetylglucosamine (yoghurt); protein dietary supplements; dietary and nutritional supplements; dietary supplement drinks; nutritional supplements mainly based on red ginseng; nutritional supplements mainly based on ginseng; nutritional supplements mainly based on glucosamine derived from shell of crustaceans (such as crabs or shrimps); nutritional supplements mainly based on N-acetylglucosamine derived from shell of crustaceans (such as crabs or shrimps, etc.); nutritional supplements mainly based on N-acetylglucosamine derived from bone of molluscs (such as squid, etc.); nutritional supplements mainly based on chitosans/chitosan oligosaccharide derived from crustaceans shell/molluscs bone; nutritional supplements mainly based on lutein derived from marigold; nutritional supplements mainly based on lactic acid bacteria; nutritional supplements mainly based on pinitol derived from carob (legumes); nutritional supplements mainly based on collagen peptide derived from pig's skin; nutritional supplements mainly based on collagen peptide derived from fish scales; nutritional supplements mainly based on fucoxanthin derived from brown algae (such as seaweed or gulf weed, etc.); nutritional supplements mainly based on ginko biloba; nutritional supplements mainly based on dietary fiber derived from psyllium husk; nutritional supplements mainly based on coenzyme Q10 derived from vegetables; nutritional supplements mainly based on isoflavone derived from soya beans; nutritional supplements mainly based on polydextrose derived from chicory roots; nutritional supplements mainly based on probiotics derived from milk products; nutritional supplements mainly based on grain enzymes; nutritional supplements mainly based on edible saccharides; nutritional supplements mainly based on leaven; nutritional supplements mainly based on fructo-oligosaccharide for culinary purposes; nutritional supplements mainly based on brown rice; nutritional supplements mainly based on fermented grain powder; nutritional supplements against hangover mainly based on grain; nutritional supplements against hangover mainly based on enzymes derived from grain; nutritional supplements mainly based on enzymes derived from grain; dietary drink mixes for loosing weight. Lactic acid bacteria drinks; food products made from beans (excluding bean curds and foodstuffs made from bean curds); food products made primarily from fruits; yoghurt; milk; processed dairy products; nut-based snack foods; preserved, frozen, dried and cooked fruits and vegetables; jellies for food; food products made from fish and shellfish; dried edible mushrooms; milkthistle being processed food; milk products; powdered milk (except for infants); processed meat products; processed vegetable products; cheese; processed seaweed products; protein milk; edible fats; milk products containing N-acetylglucosamine; processed dairy products and lactic acid bacteria drinks containing N-acetylglucosamine. Cereal-based processed products; cereal preparations; processed cereals; mixed grains powder based on grain-fermented enzymes; bay salt for food; bamboo-salt; processed foods mainly based on grain-fermented enzymes; processed foods mainly based on grain; processed grain foods against hangover; processed foods against hangover mainly based on enzymes derived from grain; processed foods mainly based on enzymes derived from grain. Non-alcoholic beverages; soft drinks; sparkling juice based beverages; mushroom drinks; barley-based beverages; vitamin enriched water [beverages]; soda water; energy drinks against hangover, not for medical purposes; sports drinks; energy drinks; carbonated water; tonic water; powders for effervescing beverages; pastilles for effervescing beverages; syrups for beverages; waters [beverages]; concentrates, syrups and powders used in the preparation of soft drinks; whey beverages; non-alcoholic beverages flavoured with tea; coconut-based beverages; N-acetylglucosamine powder for beverages; collagen peptide powder for beverages; pinitol powder for beverages; fucoxanthin powder for beverages; energy drinks containing N-acetylglucosamine derived from shell of crustaceans (such as crabs or shrimps, etc.); energy drinks containing N-acetylglucosamine derived from bone of molluscs (such as squid, etc.); energy drinks containing collagen peptide derived from pig's skin; energy drinks containing collagen peptide derived from fish scales; energy drinks containing pinitol derived from carob (legumes); energy drinks containing fucoxanthin derived from brown algae (such as seaweed or gulf weed, etc.); non-alcoholic drinks enriched with N-acetylglucosamine; non-alcoholic drinks enriched with collagen peptide; non-alcoholic drinks enriched with pinitol; non-alcoholic drinks enriched with fucoxanthin; red ginseng drinks containing N-acetylglucosamine; red ginseng drinks containing collagen peptide; red ginseng drinks containing pinitol; red ginseng drinks containing fucoxanthin; vegetable-based beverages and fruit-based beverages.

8.

Collagen-Tripep20

      
Numéro d'application 1722812
Statut Enregistrée
Date de dépôt 2023-02-17
Date d'enregistrement 2023-02-17
Propriétaire AMICOGEN, INC. (République de Corée)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser.
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 30 - Aliments de base, thé, café, pâtisseries et confiseries

Produits et services

Peptides for making processed foods; peptides (raw materials) for use in the manufacture of food; peptides (other than for medical purposes); collagen peptides for cosmetics; peptides (raw materials) for use in the manufacture of food for animals; collagen used as a raw ingredient in the manufacture of cosmetics; proteins for use in the manufacture of food supplements; proteins for use in the manufacture of food and beverages; chemical additives for use in the manufacture of food; lactose for the food industry; proteins for the food industry; amino acid for food industry; enzymes for the beverage industry; enzymes for use in the manufacture of nutraceuticals; enzyme substrates; enzymes for use in the processing of food by-products; collagen for industrial purposes; active chemical ingredients for use in the manufacture of anti-cancer drugs; active chemical ingredients; probiotic bacteria for the food industry. Collagen preparations for cosmetic purposes; herbal extracts for cosmetic purposes; body and beauty care cosmetics; nail cosmetics; cosmetics; cosmetic preparations for slimming purposes; cosmetic preparations for the hair and scalp; natural essential oils; food flavourings [essential oils]; anti-aging cosmetic preparations; sunscreen preparations; creams for cellulite reduction for cosmetic use; seaweed for cosmetology; perfumes; extracts of flowers [perfumes]; natural perfumery made from plants; perfumery; tissues impregnated with cosmetics; shampoos; soaps for personal use. Dietary supplements for infants; pharmaceutical preparations for health care; medicinal healthcare preparations; dietetic beverages adapted for medical purposes; dietary supplements; nutraceuticals for use as a dietary supplement; dietary supplements consisting of amino acids, minerals and trace elements; dietary supplements for controlling cholesterol; enzyme dietary supplements; anti-oxidant food supplements; digestive enzymes; enzymes for veterinary purposes; enzymes for medical purposes; nutraceutical preparations for therapeutic or medical purposes; synthetic peptides for pharmaceutical purposes; meal replacement powders; collagen for medical purposes; probiotic preparations for medical use; dietary supplement drink mixes; dietary supplements for pets. Meal; processed cereals; high-protein cereal bars; cereal-based snack food; processed cereals for food for human consumption; gluten prepared as foodstuff; yeast; ferments for dough; frozen yoghurt [confectionery ices]; natural sweeteners; royal jelly; molasses for food; propolis; aromatic preparations for food; garden herbs, preserved [seasonings]; spices in the form of powders; flavourings, other than essential oils, for beverages; protein-enriched coffee; cookies; flavored jelly crystals for making jelly confectionery.

9.

Chinositol

      
Numéro d'application 1722423
Statut Enregistrée
Date de dépôt 2023-02-17
Date d'enregistrement 2023-02-17
Propriétaire AMICOGEN, INC. (République de Corée)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser.
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 29 - Viande, produits laitiers et aliments préparés ou conservés

Produits et services

Peptides for making processed foods; peptides (raw materials) for use in the manufacture of food; peptides (other than for medical purposes); collagen peptides for cosmetics; peptides (raw materials) for use in the manufacture of food for animals; collagen used as a raw ingredient in the manufacture of cosmetics; proteins for use in the manufacture of food supplements; proteins for use in the manufacture of food and beverages; chemical additives for use in the manufacture of food; lactose for the food industry; proteins for the food industry; amino acid for food industry; enzymes for the beverage industry; enzymes for use in the manufacture of nutraceuticals; enzyme substrates; enzymes for use in the processing of food by-products; collagen for industrial purposes; active chemical ingredients for use in the manufacture of anti-cancer drugs; active chemical ingredients; probiotic bacteria for the food industry; lactic acid bacteria powder. Collagen preparations for cosmetic purposes; herbal extracts for cosmetic purposes; body and beauty care cosmetics; nail cosmetics; cosmetics; cosmetic preparations for slimming purposes; cosmetic preparations for the hair and scalp; natural essential oils; food flavourings [essential oils]; anti-aging cosmetic preparations; sunscreen preparations; creams for cellulite reduction for cosmetic use; seaweed for cosmetology; perfumes; extracts of flowers [perfumes]; natural perfumery made from plants; perfumery; tissues impregnated with cosmetics; shampoos; soaps for personal use. Dietary supplements for infants; pharmaceutical preparations for health care; medicinal healthcare preparations; dietetic beverages adapted for medical purposes; dietary supplements; nutraceuticals for use as a dietary supplement; dietary supplements consisting of amino acids, minerals and trace elements; enzyme dietary supplements; anti-oxidant food supplements; digestive enzymes; enzymes for veterinary purposes; enzymes for medical purposes; nutraceutical preparations for therapeutic or medical purposes; synthetic peptides for pharmaceutical purposes; meal replacement powders; collagen for medical purposes; probiotic preparations for medical use; dietary supplement drink mixes; dietary supplements for pets; nutraceuticals mainly based on bifidus bacteria; nutritional supplements mainly based on lactic acid bacteria. Preserved, frozen, dried and cooked fruits and vegetables; milk substitutes; vegetable-based snack foods; nut-based snack foods; fruit-based snack food; dried edible mushrooms; milkthistle being processed food; soup concentrates; jellies for food; yogurt; beans, preserved; milk; milk products; lactic acid drinks; cheese; seaweed extracts for food; food products made from fish and shellfish; lactic acid bacteria beverages with collagen.

10.

GreenNAG

      
Numéro d'application 1722050
Statut Enregistrée
Date de dépôt 2023-02-17
Date d'enregistrement 2023-02-17
Propriétaire AMICOGEN, INC. (République de Corée)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser.
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 29 - Viande, produits laitiers et aliments préparés ou conservés

Produits et services

Peptides for making processed foods; peptides (raw materials) for use in the manufacture of food; peptides (other than for medical purposes); collagen peptides for cosmetics; peptides (raw materials) for use in the manufacture of food for animals; collagen used as a raw ingredient in the manufacture of cosmetics; proteins for use in the manufacture of food supplements; proteins for use in the manufacture of food and beverages; chemical additives for use in the manufacture of food; lactose for the food industry; proteins for the food industry; amino acid for food industry; enzymes for the beverage industry; enzymes for use in the manufacture of nutraceuticals; enzyme substrates; enzymes for use in the processing of food by-products; collagen for industrial purposes; active chemical ingredients for use in the manufacture of anti-cancer drugs; active chemical ingredients; probiotic bacteria for the food industry; lactic acid bacteria powder. Collagen preparations for cosmetic purposes; herbal extracts for cosmetic purposes; body and beauty care cosmetics; nail cosmetics; cosmetics; cosmetic preparations for slimming purposes; cosmetic preparations for the hair and scalp; natural essential oils; food flavourings [essential oils]; anti-aging cosmetic preparations; sunscreen preparations; creams for cellulite reduction for cosmetic use; seaweed for cosmetology; perfumes; extracts of flowers [perfumes]; natural perfumery made from plants; perfumery; tissues impregnated with cosmetics; shampoos; soaps for personal use. Dietary supplements for infants; pharmaceutical preparations for health care; medicinal healthcare preparations; dietetic beverages adapted for medical purposes; dietary supplements; nutraceuticals for use as a dietary supplement; dietary supplements consisting of amino acids, minerals and trace elements; enzyme dietary supplements; anti-oxidant food supplements; digestive enzymes; enzymes for veterinary purposes; enzymes for medical purposes; nutraceutical preparations for therapeutic or medical purposes; synthetic peptides for pharmaceutical purposes; meal replacement powders; collagen for medical purposes; probiotic preparations for medical use; dietary supplement drink mixes; dietary supplements for pets; nutraceuticals mainly based on bifidus bacteria; nutritional supplements mainly based on lactic acid bacteria. Preserved, frozen, dried and cooked fruits and vegetables; milk substitutes; vegetable-based snack foods; nut-based snack foods; fruit-based snack food; dried edible mushrooms; milk thistle being processed food; soup concentrates; jellies for food; yogurt; beans, preserved; milk; milk products; lactic acid drinks; cheese; seaweed extracts for food; food products made from fish and shellfish; lactic acid bacteria beverages with collagen.

11.

CureZyme-LAC

      
Numéro d'application 1722051
Statut Enregistrée
Date de dépôt 2023-02-17
Date d'enregistrement 2023-02-17
Propriétaire AMICOGEN, INC. (République de Corée)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser.
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 29 - Viande, produits laitiers et aliments préparés ou conservés

Produits et services

Peptides for making processed foods; peptides (raw materials) for use in the manufacture of food; peptides (other than for medical purposes); collagen peptides for cosmetics; peptides (raw materials) for use in the manufacture of food for animals; collagen used as a raw ingredient in the manufacture of cosmetics; proteins for use in the manufacture of food supplements; proteins for use in the manufacture of food and beverages; chemical additives for use in the manufacture of food; lactose for the food industry; proteins for the food industry; amino acid for food industry; enzymes for the beverage industry; enzymes for use in the manufacture of nutraceuticals; enzyme substrates; enzymes for use in the processing of food by-products; collagen for industrial purposes; active chemical ingredients for use in the manufacture of anti-cancer drugs; active chemical ingredients; probiotic bacteria for the food industry; lactic acid bacteria powder. Collagen preparations for cosmetic purposes; herbal extracts for cosmetic purposes; body and beauty care cosmetics; nail cosmetics; cosmetics; cosmetic preparations for slimming purposes; cosmetic preparations for the hair and scalp; natural essential oils; food flavourings [essential oils]; anti-aging cosmetic preparations; sunscreen preparations; creams for cellulite reduction for cosmetic use; seaweed for cosmetology; perfumes; extracts of flowers [perfumes]; natural perfumery made from plants; perfumery; tissues impregnated with cosmetics; shampoos; soaps for personal use. Dietary supplements for infants; pharmaceutical preparations for health care; medicinal healthcare preparations; dietetic beverages adapted for medical purposes; dietary supplements; nutraceuticals for use as a dietary supplement; dietary supplements consisting of amino acids, minerals and trace elements; enzyme dietary supplements; anti-oxidant food supplements; digestive enzymes; enzymes for veterinary purposes; enzymes for medical purposes; nutraceutical preparations for therapeutic or medical purposes; synthetic peptides for pharmaceutical purposes; meal replacement powders; collagen for medical purposes; probiotic preparations for medical use; dietary supplement drink mixes; dietary supplements for pets; nutraceuticals mainly based on bifidus bacteria; nutritional supplements mainly based on lactic acid bacteria. Preserved, frozen, dried and cooked fruits and vegetables; milk substitutes; vegetable-based snack foods; nut-based snack foods; fruit-based snack food; dried edible mushrooms; milk thistle being processed food; soup concentrates; jellies for food; yogurt; beans, preserved; milk; milk products; lactic acid drinks; cheese; seaweed extracts for food; food products made from fish and shellfish; lactic acid bacteria beverages with collagen.

12.

CureZyme-ACE

      
Numéro d'application 1722052
Statut Enregistrée
Date de dépôt 2023-02-17
Date d'enregistrement 2023-02-17
Propriétaire AMICOGEN, INC. (République de Corée)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser.
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 29 - Viande, produits laitiers et aliments préparés ou conservés

Produits et services

Peptides for making processed foods; peptides (raw materials) for use in the manufacture of food; peptides (other than for medical purposes); collagen peptides for cosmetics; peptides (raw materials) for use in the manufacture of food for animals; collagen used as a raw ingredient in the manufacture of cosmetics; proteins for use in the manufacture of food supplements; proteins for use in the manufacture of food and beverages; chemical additives for use in the manufacture of food; lactose for the food industry; proteins for the food industry; amino acid for food industry; enzymes for the beverage industry; enzymes for use in the manufacture of nutraceuticals; enzyme substrates; enzymes for use in the processing of food by-products; collagen for industrial purposes; active chemical ingredients for use in the manufacture of anti-cancer drugs; active chemical ingredients; probiotic bacteria for the food industry; lactic acid bacteria powder. Collagen preparations for cosmetic purposes; herbal extracts for cosmetic purposes; body and beauty care cosmetics; nail cosmetics; cosmetics; cosmetic preparations for slimming purposes; cosmetic preparations for the hair and scalp; natural essential oils; food flavourings [essential oils]; anti-aging cosmetic preparations; sunscreen preparations; creams for cellulite reduction for cosmetic use; seaweed for cosmetology; perfumes; extracts of flowers [perfumes]; natural perfumery made from plants; perfumery; tissues impregnated with cosmetics; shampoos; soaps for personal use. Dietary supplements for infants; pharmaceutical preparations for health care; medicinal healthcare preparations; dietetic beverages adapted for medical purposes; dietary supplements; nutraceuticals for use as a dietary supplement; dietary supplements consisting of amino acids, minerals and trace elements; enzyme dietary supplements; anti-oxidant food supplements; digestive enzymes; enzymes for veterinary purposes; enzymes for medical purposes; nutraceutical preparations for therapeutic or medical purposes; synthetic peptides for pharmaceutical purposes; meal replacement powders; collagen for medical purposes; probiotic preparations for medical use; dietary supplement drink mixes; dietary supplements for pets; nutraceuticals mainly based on bifidus bacteria; nutritional supplements mainly based on lactic acid bacteria. Preserved, frozen, dried and cooked fruits and vegetables; milk substitutes; vegetable-based snack foods; nut-based snack foods; fruit-based snack food; dried edible mushrooms; milk thistle being processed food; soup concentrates; jellies for food; yogurt; beans, preserved; milk; milk products; lactic acid drinks; cheese; seaweed extracts for food; food products made from fish and shellfish; lactic acid bacteria beverages with collagen.

13.

Collagen Peptide-Optima

      
Numéro d'application 1718954
Statut Enregistrée
Date de dépôt 2023-02-17
Date d'enregistrement 2023-02-17
Propriétaire AMICOGEN, INC. (République de Corée)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser.
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 30 - Aliments de base, thé, café, pâtisseries et confiseries

Produits et services

Peptides for making processed foods; peptides (raw materials) for use in the manufacture of food; peptides (other than for medical purposes); collagen peptides for cosmetics; peptides (raw materials) for use in the manufacture of food for animals; collagen used as a raw ingredient in the manufacture of cosmetics; proteins for use in the manufacture of food supplements; proteins for use in the manufacture of food and beverages; chemical additives for use in the manufacture of food; lactose for the food industry; proteins for the food industry; amino acid for food industry; enzymes for the beverage industry; enzymes for use in the manufacture of nutraceuticals; enzyme substrates; enzymes for use in the processing of food by-products; collagen for industrial purposes; active chemical ingredients for use in the manufacture of anti-cancer drugs; active chemical ingredients; probiotic bacteria for the food industry. Collagen preparations for cosmetic purposes; herbal extracts for cosmetic purposes; body and beauty care cosmetics; nail cosmetics; cosmetics; cosmetic preparations for slimming purposes; cosmetic preparations for the hair and scalp; natural essential oils; food flavourings [essential oils]; anti-aging cosmetic preparations; sunscreen preparations; creams for cellulite reduction for cosmetic use; seaweed for cosmetology; perfumes; extracts of flowers [perfumes]; natural perfumery made from plants; perfumery; tissues impregnated with cosmetics; shampoos; soaps for personal use. Dietary supplements for infants; pharmaceutical preparations for health care; medicinal healthcare preparations; dietetic beverages adapted for medical purposes; dietary supplements; nutraceuticals for use as a dietary supplement; dietary supplements consisting of amino acids, minerals and trace elements; dietary supplements for controlling cholesterol; enzyme dietary supplements; anti-oxidant food supplements; digestive enzymes; enzymes for veterinary purposes; enzymes for medical purposes; nutraceutical preparations for therapeutic or medical purposes; synthetic peptides for pharmaceutical purposes; meal replacement powders; collagen for medical purposes; probiotic preparations for medical use; dietary supplement drink mixes; dietary supplements for pets. Meal; processed cereals; high-protein cereal bars; cereal-based snack food; processed cereals for food for human consumption; gluten prepared as foodstuff; yeast; ferments for pastes; frozen yoghurt [confectionery ices]; natural sweeteners; royal jelly; molasses for food; propolis; aromatic preparations for food; garden herbs, preserved [seasonings]; spices in the form of powders; flavourings, other than essential oils, for beverages; protein-enriched coffee; cookies; flavored jelly crystals for making jelly confectionery.

14.

K K·NUTRA

      
Numéro de série 97358518
Statut En instance
Date de dépôt 2022-04-12
Propriétaire AMICOGEN, INC. (République de Corée)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Capsules for medicines, namely, pharmaceutical agents affecting digestive organs; health functional food containing glucosamine extracted from shellfish such as crab or shrimp, namely, food for enteral feeding; health functional food containing N-acetylglucosamine extracted from shellfish such as crab or shrimp, namely, food for enteral feeding; health functional food containing N-acetylglucosamine extracted from the bones of mollusks such as squid as the main ingredient, namely, food for enteral feeding; health functional food made from chitosan or chitooligosaccharides extracted from crustacean shells or mollusk bonds, namely, food for enteral feeding; health functional food with collagen peptide extracted from pig skin as the main ingredient, namely, food for enteral feeding; health functional food using collagen peptides extracted from fish scales as the main ingredient, namely, food for enteral feeding

15.

NOVEL ASPERGILLUS NIGER AG1 STRAIN AND METHOD FOR PREPARING COMPOUND K BY USING SAME

      
Numéro d'application KR2021012519
Numéro de publication 2022/060057
Statut Délivré - en vigueur
Date de dépôt 2021-09-14
Date de publication 2022-03-24
Propriétaire AMICOGEN, INC. (République de Corée)
Inventeur(s)
  • Shin, Yong Chul
  • Piao, Zhe
  • Jo, Hyun Jung
  • Jang, Jae Hyeok
  • Yun, Young Sung
  • Kim, Jin Seok

Abrégé

The present invention relates to a novel Aspergillus niger AG1 strain and, more specifically, to: a method for preparing β-glycosidase, comprising a step of culturing the strain; a method for preparing compound K, comprising a step in which β-glycosidase derived from the strain comes into contact with a substrate; and a food composition, a cosmetic composition and a pharmaceutical composition, containing, as an active ingredient, compound K produced by means of the compound K preparation method.

Classes IPC  ?

  • C12N 1/14 - ChampignonsLeurs milieux de culture
  • C12N 9/24 - Hydrolases (3.) agissant sur les composés glycosyliques (3.2)
  • C12P 33/20 - Préparation de stéroïdes contenant des hétérocycles
  • A23L 29/00 - Aliments ou produits alimentaires contenant des additifsLeur préparation ou leur traitement
  • A61K 8/63 - StéroïdesLeurs dérivés
  • A61Q 19/00 - Préparations pour les soins de la peau
  • A61K 31/56 - Composés contenant des systèmes cycliques du cyclopenta[a]hydrophénanthrèneLeurs dérivés, p. ex. stéroïdes
  • A61P 17/10 - Antiacnéïques
  • A61P 3/10 - Médicaments pour le traitement des troubles du métabolisme de l'homéostase du glucose de l'hyperglycémie, p. ex. antidiabétiques
  • A61P 25/28 - Médicaments pour le traitement des troubles du système nerveux des troubles dégénératifs du système nerveux central, p. ex. agents nootropes, activateurs de la cognition, médicaments pour traiter la maladie d'Alzheimer ou d'autres formes de démence

16.

CUREZYME-LAC

      
Numéro de série 97282759
Statut Enregistrée
Date de dépôt 2022-02-24
Date d'enregistrement 2023-12-26
Propriétaire AMICOGEN, INC. (République de Corée)
Classes de Nice  ? 30 - Aliments de base, thé, café, pâtisseries et confiseries

Produits et services

Processed cereals; cereal-based processed products, namely, namely, cereal-bars; foods and health functional foods containing enzymes made by fermenting grains, namely, cereal based snack foods; food made from fermented grain enzymes, namely, processed grains; grain-based foods and health functional foods, namely, grain-based snack foods; cereal preparations, namely, cereal-bars; health functional food containing grain enzymes as the main ingredient, namely, grain-based snack foods

17.

AMICOGEN

      
Numéro de série 97282756
Statut Enregistrée
Date de dépôt 2022-02-24
Date d'enregistrement 2025-11-18
Propriétaire AMICOGEN, INC. (République de Corée)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 29 - Viande, produits laitiers et aliments préparés ou conservés
  • 30 - Aliments de base, thé, café, pâtisseries et confiseries
  • 32 - Bières; boissons non alcoolisées

Produits et services

Medicinal tonics, namely, mineral, vitamin, or nutritionally enhanced water for medical purposes; pharmaceutical preparations to regulate an immune system; mineral nutritional supplements; mineral supplements; nutritive substances for microorganisms for medical purposes; vitamin tablets; vitamin preparations; pharmaceutical products for the treatment of bone diseases; fungicides; insecticides; medium for bacterial culture, namely, bacteriological culture mediums; food for infants; ferments for medical or veterinary use; adjuvants for medical purposes; fodder additives in the nature of dietary supplements for medical purposes; medical nutritional supplements; calcium supplements; anti-diabetic pharmaceuticals; hypoglycemic agents; mixed vitamins; health functional food with ginseng as the main ingredient, namely, dietetic foods adapted for medical use; health food supplement made with lactic acid bacteria as the main ingredient; a health food supplement made with calcium from seaweed as the main ingredient; health food supplements containing EPA/DHA ingredients from edible fish; health food supplements with aloe extract as the main ingredient; a health food supplement containing chitosan extracted from crabs; Health dietary supplement drink mixes with protein, amino acids, and calcium extracted from milk; a health dietary supplement drink mix made with carbohydrates and vitamins extracted from fruits Health functional food with ginseng as the main ingredient, namely, vegetable-based snack food; health functional food with red ginseng as the main ingredient, namely, vegetable-based snack food; health functional food with refined fish oil as the main ingredient, namely, powdered oils and fats for food; health functional food containing garcinia cambogia extract as the main ingredient, namely, vegetable-based snack foods; health functional food containing glucosamine extracted from the shells of crustaceans, namely, fish-based snack food; a health functional food containing N-acetylglucosamine extracted from shellfish shells as the main ingredient, namely, fish-based snack food; health functional food containing chitosan extracted from the shells of crustaceans, namely, fish-based snack food; health functional food containing chitooligosaccharide extracted from the shells of crustaceans, namely, fish-based snack food; health functional food with collagen extracted from fish scales as the main ingredient, namely, fish-based snack food; health functional food with collagen peptide extracted from fish scales as the main ingredient, namely, fish-based snack food; health functional food with collagen extracted from pig skin as the main ingredient, namely, meat-based snack food; health functional food with collagen peptide extracted from pig skin as the main ingredient, namely, jellies, jams; health functional food with fucoxanthin extracted from seaweed as the main ingredient, namely, seaweed-based snacks; Health functional food containing lactic acid bacteria as the main ingredient, namely, lactic acid bacteria drinks; health functional food containing vitamin B group such as B1, B2, B12 as the main ingredient, namely, fungal extracts for use as ingredients of nutritional supplements and vitamins; Health functional food containing folic acid such as folinic acid as the main ingredient, namely, lactic acid drinks; processed ginseng for use as a vegetable; processed red ginseng for use as a vegetable; lactic acid bacteria drink Processed cereals; food leavening agents; fructo-oligosaccharide for culinary purposes in the nature of fructose for food; muesli; cereal-based processed products, namely, cereal bars; oat-based food, namely, processed oats; farinaceous food pastes for human consumption; oatmeal; Korean rice-wine starter in the nature of yeast, namely, Nuruk; baking powders; ferments for pastes, namely, dough ferments for culinary purposes; malt for food purposes; vinegar; ketchup; processed coffee; cereal preparations, namely, processed cereals; beverages with a tea base; glucose for food, namely, glucose for culinary purposes; Confectionery, namely, pastilles for effervescing beverages; Processed ginseng extract used as a flavoring for drinks Health functional beverage made from glucosamine extracted from shellfish shells in the nature of non-alcoholic water-based beverages; health functional beverage made with N-acetylglucosamine extracted from shellfish shells in the nature of non-alcoholic water-based beverages; a functional health drink containing chitooligosaccharide extracted from the shells of crustaceans as the main ingredient in the nature of non-alcoholic water-based beverages; a health functional beverage made with collagen extracted from fish scales as the main ingredient in the nature of non-alcoholic water-based beverages; a health functional beverage made from collagen peptides extracted from fish scales in the nature of non-alcoholic water-based beverages; a health functional beverage made with collagen extracted from pig skin as the main ingredient in the nature of non-alcoholic water-based beverages; a health functional beverage made with collagen peptides extracted from pig skin as the main ingredient in the nature of non-alcoholic water-based beverages; functional health drink with fucoxanthin extracted from seaweed as the main ingredient in the nature of non-alcoholic water-based beverages; health functional beverage containing vitamin C as the main ingredient in the nature of non-alcoholic water-based beverages; health functional beverage with coenzyme Q10 as the main ingredient in the nature of non-alcoholic water-based beverages; health functional beverage made with ginseng as the main ingredient in the nature of non-alcoholic beverages containing ginseng juice; Health functional beverage made with red ginseng as the main ingredient in the nature of non-alcoholic beverages containing red ginseng juice; health functional beverage made with soybean oil as the main ingredient in the nature of non-alcoholic water-based beverages; health functional beverage with evening primrose oil as the main ingredient in the nature of non-alcoholic water-based beverages; Health supplement drink with protein/amino acids/calcium extracted from milk in the nature of non-alcoholic water-based beverages; a health supplement drink made with carbohydrates/vitamins extracted from fruits in the nature of non-alcoholic water-based beverages; health functional beverage with garcinia cambogia extract as the main ingredient in the nature of non-alcoholic water-based beverages; functional food and drink for diet, namely, non-alcoholic vegetable juice beverages

18.

PENICILLIN G ACYLASE MUTANT HAVING INCREASED CEFAZOLINE PRODUCTIVITY AND USE THEREOF

      
Numéro d'application KR2020016010
Numéro de publication 2021/096298
Statut Délivré - en vigueur
Date de dépôt 2020-11-13
Date de publication 2021-05-20
Propriétaire AMICOGEN, INC. (République de Corée)
Inventeur(s)
  • Shin, Yong Chul
  • Piao, Zhe
  • Wang, Eun Seon
  • Yun, Young Sung
  • Kim, Na Ri
  • Kang, Mi Suk

Abrégé

The present invention relates to a penicillin G acylase mutant having increased cefazoline productivity and a use thereof, wherein Achromobacter sp. CCM 4824-derived penicillin G acylase mutants having unique mutation forms disclosed in the present invention have a very high synthesis activity specifically for cefazoline, compared to wild-type enzyme thereof and other known mutant forms, and have a remarkably high synthesis ratio (S/H ratio) compared to the degradation activity of a substrate used for synthesis of cefazoline, and thus the productivity of cefazoline is remarkably increased to a significant level in industrial applications.

Classes IPC  ?

  • C12N 9/84 - Penicillinamidase
  • C12P 35/04 - Préparation de composés comportant un système cyclique thia-5 aza-1 bicyclo [4.2.0] octane, p. ex. céphalosporine par acylation du substituant en position 7

19.

METHOD FOR PREPARING RECOMBINANT ACREMONIUM CHRYSOGENUM STRAIN PRODUCING HIGH CONCENTRATION OF DEACETOXYCEPHALOSPROIN C FOR PREPARATION OF 7-ADCA, AND STRAIN PREPARED BY SAME METHOD

      
Numéro d'application KR2020001711
Numéro de publication 2021/054545
Statut Délivré - en vigueur
Date de dépôt 2020-02-06
Date de publication 2021-03-25
Propriétaire AMICOGEN, INC. (République de Corée)
Inventeur(s)
  • Shin, Yong Chul
  • Piao, Zhe
  • Yoon, Sang Hwal
  • Lee, Hyeon Seo
  • Kang, Mi Suk
  • Piao, Xuemei
  • Kim, You Mi
  • Li, Hong Xian
  • Jeong, Dong Won
  • Shim, Jae Min
  • Jung, Jang Hyun
  • Seo, Dong Il
  • Kim, Seung Ki

Abrégé

The present invention relates to a method for preparing a recombinant acremonium chrysogenum strain producing a high concentration of deacetoxycephalosporin C (DAOC), and a strain prepared by same method and, more specifically, to a method for preparing an acremonium chrysogenum strain producing DAOC with high yield, a recombinant acremonium chrysogenum strain prepared by same method, a DAOC production method for culturing the strain under conditions capable of producing DAOC and recovering the DAOC, a polynucleotide for high DAOC expression in the acremonium chrysogenum strain used in the production method, an expression vector for high DAOC expression in the acremonium chrysogenum strain, and a method for producing 7-ADCA by treating the produced DAOC with CPC acylase.

Classes IPC  ?

  • C12N 9/10 - Transférases (2.)
  • C12N 9/02 - Oxydoréductases (1.), p. ex. luciférase
  • C12P 35/00 - Préparation de composés comportant un système cyclique thia-5 aza-1 bicyclo [4.2.0] octane, p. ex. céphalosporine

20.

ANTIBODY PURIFYING RESIN HAVING EXCELLENT IMPURITY REMOVAL POTENTIAL

      
Numéro d'application KR2019003414
Numéro de publication 2020/196938
Statut Délivré - en vigueur
Date de dépôt 2019-03-25
Date de publication 2020-10-01
Propriétaire
  • AMICOGEN, INC. (République de Corée)
  • BIO-WORKS TECHNOLOGIES AB (Suède)
Inventeur(s)
  • Shin, Yong Chul
  • Piao, Zhe
  • Choi, Su-Lim
  • Park, So-Young
  • Park, Sol A
  • Mesas, Laura
  • Abrahamsson, Erik
  • Idström, Alex
  • Huang, Xiao
  • Röhnisch, Kajsa Eriksson
  • Unoson, Cecilia
  • Haneskog, Lars

Abrégé

The present invention relates to an antibody-purifying resin having an excellent impurity removal potential and, more particularly, to an antibody-purifying resin wherein a part of amino acid residues of protein A is substituted, whereby the resin can exhibit an excellent potential to remove impurities such as host cell-derived proteins (HCP), host cell-derived DNA (HCD), etc. Having an excellent potential of removing host cell-derived impurities, the resin according to the present invention allows the omission of subsequent processes for removing impurities in the antibody purification procedure therethrough or the reduction of a load of impurities to be treated in subsequent processes, whereby the resin can be used for an increased number of cycles in a subsequent process-friendly manner.

Classes IPC  ?

  • C07K 1/22 - Chromatographie d'affinité ou techniques analogues basées sur des procédés d'absorption sélective
  • C07K 16/06 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux provenant de sérum
  • B01J 20/32 - Imprégnation ou revêtement

21.

ACETYLCHOLINE RECEPTOR INHIBITORY PEPTIDES AND USES THEREOF

      
Numéro d'application KR2019018460
Numéro de publication 2020/138948
Statut Délivré - en vigueur
Date de dépôt 2019-12-26
Date de publication 2020-07-02
Propriétaire AMICOGEN, INC. (République de Corée)
Inventeur(s)
  • Kim, Sung Hyun
  • Choi, Won Il
  • Shin, Yong Chul
  • Yun, Young Sung
  • Kim, Jin Hwa
  • Lee, Jeung Hoon

Abrégé

The present invention relates to acetylcholine receptor inhibitory peptides and uses thereof, wherein phages with high binding affinity for acetylcholine receptors were screened using a random peptide recombinant phage, and acetylcholine receptor-binding peptides were selected through DNA of the phages. By having confirmed, using the selected peptides, the binding affinity for acetylcholine receptors and the effect of inhibiting the action of acetylcholine receptors, and having confirmed, via the modifications of the peptides, peptide sites and sequences that are vital in binding to acetylcholine receptors, the acetylcholine receptor inhibitory peptides of the present invention are expected to be used in the development of a cosmetic composition for alleviating wrinkles, a medicine for the prevention or treatment of acetylcholine receptor-associated diseases, and a health functional food for the amelioration thereof.

Classes IPC  ?

  • C07K 7/06 - Peptides linéaires ne contenant que des liaisons peptidiques normales ayant de 5 à 11 amino-acides
  • A23L 33/18 - PeptidesHydrolysats de protéines
  • A61K 8/64 - ProtéinesPeptidesLeurs dérivés ou produits de dégradation
  • A61P 25/14 - Médicaments pour le traitement des troubles du système nerveux pour traiter les mouvements anormaux, p. ex. chorée, dyskinésie
  • A61Q 19/00 - Préparations pour les soins de la peau
  • A61K 38/00 - Préparations médicinales contenant des peptides

22.

Mutated immunoglobulin-binding protein having increased alkaline tolerance

      
Numéro d'application 16240074
Numéro de brevet 10766933
Statut Délivré - en vigueur
Date de dépôt 2019-01-04
Date de la première publication 2019-07-04
Date d'octroi 2020-09-08
Propriétaire Amicogen, Inc. (République de Corée)
Inventeur(s)
  • Shin, Yong Chul
  • Piao, Zhe
  • Choi, Su-Lim
  • Jo, Yang Ho
  • Park, So-Young
  • Kwon, Dae Beom

Abrégé

The present invention relates to a mutated immunoglobulin-binding protein having increased alkaline tolerance and, more specifically, to an immunoglobulin-binding protein in which, with respect to the A-domain of Staphylococcal protein A, or a functional variant thereof, an amino acid at a specific site is mutated and thereby exhibits an increased chemical stability at an alkaline pH value in comparison to a parental molecule. The present invention can provide an antibody-purifying immunoglobulin-binding protein ligand and matrix which have enhanced alkaline tolerance and accordingly enhanced stability in multiple times of alkaline cleaning.

Classes IPC  ?

  • C07K 14/31 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant de bactéries provenant de Micrococcaceae (F) provenant de Staphylococcus (G)
  • B01D 15/38 - Adsorption sélective, p. ex. chromatographie caractérisée par le mécanisme de séparation impliquant une interaction spécifique non couverte par un ou plusieurs des groupes , p. ex. chromatographie d'affinité, chromatographie d'échange par ligand ou chromatographie chirale
  • C07K 1/12 - Procédés généraux de préparation de peptides par hydrolyse

23.

ACETYLCHOLINE RECEPTOR-BINDING PEPTIDE

      
Numéro d'application KR2018007170
Numéro de publication 2019/004674
Statut Délivré - en vigueur
Date de dépôt 2018-06-25
Date de publication 2019-01-03
Propriétaire
  • KOREA INSTITUTE OF CERAMIC ENGINEERING AND TECHNOLOGY (République de Corée)
  • AMICOGEN, INC. (République de Corée)
Inventeur(s)
  • Kim, Sung Hyun
  • Choi, Won Il
  • Shin, Yong Chul
  • Lee, Jeung Hoon
  • Yun, Young Sung
  • Kim, Jin Hwa

Abrégé

The present invention relates to an acetylcholine receptor-binding peptide and, more particularly, to a novel peptide that blocks the release of acetylcholine by binding to an acetylcholine receptor on which acetylcholine acts, thus exerting a reductive effect on wrinkles. A peptide according to the present invention has strong affinity for an acetylcholine receptor and thus binds strongly to acetylcholine to repress the release of acetylcholine, whereby a cosmetic composition and a pharmaceutical composition, each comprising the peptide of the present invention as an effective ingredient, exhibit superb wrinkle reduction effects.

Classes IPC  ?

  • C07K 7/06 - Peptides linéaires ne contenant que des liaisons peptidiques normales ayant de 5 à 11 amino-acides
  • C07K 7/08 - Peptides linéaires ne contenant que des liaisons peptidiques normales ayant de 12 à 20 amino-acides
  • A61K 8/64 - ProtéinesPeptidesLeurs dérivés ou produits de dégradation
  • A61Q 19/08 - Préparations contre le vieillissement
  • G01N 33/68 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des protéines, peptides ou amino-acides
  • A61K 38/00 - Préparations médicinales contenant des peptides

24.

METHOD FOR PRODUCING RECOMBINANT ACREMONIUM CHRYSOGENUM STRAIN PRODUCING 7-AMINOCEPHALOSPORANIC ACID AT HIGH CONCENTRATION, AND STRAIN PRODUCED USING METHOD

      
Numéro d'application KR2017009330
Numéro de publication 2018/038577
Statut Délivré - en vigueur
Date de dépôt 2017-08-25
Date de publication 2018-03-01
Propriétaire AMICOGEN, INC. (République de Corée)
Inventeur(s)
  • Shin, Yong Chul
  • Piao, Zhe
  • Yoon, Sang Hwal
  • Lee, Hyeon Seo
  • Choi, Yeon Hee
  • Kim, Eun Jung

Abrégé

Acremonium chrysogenumAcremonium chrysogenumAcremonium chrysogenumAcremonium chrysogenumAcremonium chrysogenumAcremonium chrysogenumAcremonium chrysogenum strain and fermenting the same.

Classes IPC  ?

  • C12N 15/80 - Vecteurs ou systèmes d'expression spécialement adaptés aux hôtes eucaryotes pour champignons
  • C12N 9/80 - Hydrolases (3.) agissant sur les liaisons carbone-azote autres que les liaisons peptidiques (3.5) agissant sur les liaisons amides des amides aliphatiques
  • C12P 35/06 - Céphalosporine CSes dérivés

25.

MUTATED IMMUNOGLOBULIN-BINDING PROTEIN HAVING INCREASED ALKALINE TOLERANCE

      
Numéro d'application KR2017007248
Numéro de publication 2018/009006
Statut Délivré - en vigueur
Date de dépôt 2017-07-06
Date de publication 2018-01-11
Propriétaire AMICOGEN, INC. (République de Corée)
Inventeur(s)
  • Shin, Yong Chul
  • Piao, Zhe
  • Choi, Su-Lim
  • Jo, Yang Ho
  • Park, So-Young
  • Kwon, Dae Beom

Abrégé

The present invention relates to a mutated immunoglobulin-binding protein having increased alkaline tolerance and, more specifically, to an immunoglobulin-binding protein in which, with respect to the A-domain of Staphylococcal protein A, or a functional variant thereof, an amino acid at a specific site is mutated and thereby exhibits an increased chemical stability at an alkaline pH value in comparison to a parental molecule. The present invention can provide an antibody-purifying immunoglobulin-binding protein ligand and matrix which have enhanced alkaline tolerance and accordingly enhanced stability in multiple times of alkaline cleaning.

Classes IPC  ?

  • C07K 14/31 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant de bactéries provenant de Micrococcaceae (F) provenant de Staphylococcus (G)
  • C07K 1/22 - Chromatographie d'affinité ou techniques analogues basées sur des procédés d'absorption sélective
  • B01D 15/38 - Adsorption sélective, p. ex. chromatographie caractérisée par le mécanisme de séparation impliquant une interaction spécifique non couverte par un ou plusieurs des groupes , p. ex. chromatographie d'affinité, chromatographie d'échange par ligand ou chromatographie chirale

26.

COLLAGEN HYDROLYSATE CONTAINING HIGH CONTENT OF COLLAGEN TRIPEPTIDE AND USE THEREOF

      
Numéro d'application KR2017001217
Numéro de publication 2017/135754
Statut Délivré - en vigueur
Date de dépôt 2017-02-03
Date de publication 2017-08-10
Propriétaire AMICOGEN, INC. (République de Corée)
Inventeur(s)
  • Shin, Yong Chul
  • Piao, Zhe
  • Choi, Su-Lim
  • Kim, Yi Soo
  • Kim, Hyun A
  • Cho, Yun Young
  • Chung, Hye Jin

Abrégé

The present invention relates to a collagen hydrolysate with a high content of collagen tripeptides, and the use thereof and, more particularly, to a collagen hydrolysate prepared by using a collagenase that specifically produces a predominant amount of collagen tripeptides and a composition comprising the same as an effective ingredient for preventing hair loss and/or for promoting hair regrowth. Remarkably rich in collagen tripeptide content compared to previously reported collagen hydrates, the collagen hydrolysate of the present invention has an outstanding absorption rate in the body and exhibits an excellent capability of preventing hair loss and promoting hair regrowth and an excellent effect of improving skin wrinkles and/or moisturizing the skin.

Classes IPC  ?

  • C07K 14/78 - Peptides du tissu connectif, p. ex. collagène, élastine, laminine, fibronectine, vitronectine ou globuline insoluble à froid [CIG]
  • C07K 1/12 - Procédés généraux de préparation de peptides par hydrolyse
  • C07K 1/18 - Chromatographie d'échange d'ions
  • B01D 15/36 - Adsorption sélective, p. ex. chromatographie caractérisée par le mécanisme de séparation impliquant une interaction ionique, p. ex. échange d'ions, paire d'ions, suppression d'ions ou exclusion d'ions
  • A23L 33/18 - PeptidesHydrolysats de protéines
  • A61K 8/65 - CollagèneGélatineKératineLeurs dérivés ou produits de dégradation
  • A61K 38/01 - Protéines hydrolyséesLeurs dérivés
  • A61Q 9/04 - Dépilatoires

27.

COMPOSITION FOR PREVENTING OR TREATING LIPID METABOLIC DISORDERS COMPRISING FUCOXANTHIN OR MARINE PLANT EXTRACT CONTAINING SAME

      
Numéro d'application KR2008005868
Numéro de publication 2009/048249
Statut Délivré - en vigueur
Date de dépôt 2008-10-07
Date de publication 2009-04-16
Propriétaire AMICOGEN, INC. (République de Corée)
Inventeur(s)
  • Shin, Yong Chul
  • Choi, Myung-Sook
  • Woo, Myoung-Nam
  • Jung, Kyung Hwa
  • Kim, Ki Seok

Abrégé

The present invention relates to a composition for the prevention or treatment lipid metabolic disorders comprising fucoxanthin or marine plant extract comtaining the same as an effective indredients. Fucoxanthin or a marine plant extract comprising the same is effective in reducing weight increase and reducing triglyceride and cholesterol level in liver tissue, or plasma through inhibiting the synthesis of fatty acid and promoting the oxidation of fatty acid. Therefore, the composition comprising fucoxanthin or a marine plant extract comprising the same as an effective ingredient may be effectively used for the prevention and treatment of lipid metabolic disorders.

Classes IPC  ?

  • A61K 31/336 - Composés hétérocycliques ayant l'oxygène comme seul hétéro-atome d'un cycle, p. ex. fungichromine ayant des cycles à trois chaînons, p. ex. oxirane, fumagilline